XML 17 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Retained Earnings
Non-controlling Interest
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Sep. 30, 2024       14,687,000 1,430,000        
Beginning balance at Sep. 30, 2024 $ 390,753     $ 147 $ 14 $ 202,921 $ 159,625 $ 29,943 $ (1,897)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (13,612)           (11,971) (1,641)  
Shares issued upon vesting of equity-based awards, net of tax withholding (in shares)       160,000          
Shares issued upon vesting of equity-based awards, net of tax withholding (1,823)     $ 1   (1,824)      
Equity-based compensation 2,170         2,170      
Currency translation adjustment 20             2 18
Tax expense (benefit) (1,200)                
Change in fair value of interest rate swaps, net of reclassification adjustment and tax expense 6,110             537 5,573
Ending balance (in shares) at Dec. 31, 2024       14,847,000 1,430,000        
Ending balance at Dec. 31, 2024 383,618     $ 148 $ 14 203,267 147,654 28,841 3,694
Beginning balance (in shares) at Sep. 30, 2024       14,687,000 1,430,000        
Beginning balance at Sep. 30, 2024 390,753     $ 147 $ 14 202,921 159,625 29,943 (1,897)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (13,987)                
Ending balance (in shares) at Mar. 31, 2025       16,313,000 0        
Ending balance at Mar. 31, 2025 381,615     $ 163 $ 0 232,981 147,286 0 1,185
Beginning balance (in shares) at Dec. 31, 2024       14,847,000 1,430,000        
Beginning balance at Dec. 31, 2024 383,618     $ 148 $ 14 203,267 147,654 28,841 3,694
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (375)           (368) (7)  
Distributions to members (186)             (186)  
Exchange of B shares for A shares (in shares)       1,430,000 (1,430,000)        
Exchange of B shares for A shares 0     $ 14 $ (14) 28,295   (28,598) 303
Establishment of liabilities under tax receivable agreement and related changes to deferred tax assets associated with increases in tax basis (1,203)         (1,203)      
Shares issued as part of employee stock purchase plan (in shares)       36,000          
Shares issued as part of employee stock purchase plan 535     $ 1   534      
Equity-based compensation 2,088         2,088      
Currency translation adjustment (21)               (21)
Tax expense (benefit) 900                
Change in fair value of interest rate swaps, net of reclassification adjustment and tax expense (2,841)             (50) (2,791)
Ending balance (in shares) at Mar. 31, 2025       16,313,000 0        
Ending balance at Mar. 31, 2025 381,615     $ 163 $ 0 232,981 147,286 0 1,185
Beginning balance (in shares) at Sep. 30, 2025   16,373,991 0 16,374,000 0        
Beginning balance at Sep. 30, 2025 284,953     $ 164 $ 0 240,478 44,954 0 (643)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (7,711)           (7,711)    
Exchange of B shares for A shares (in shares)   1,429,940 1,429,940            
Shares issued upon vesting of equity-based awards, net of tax withholding (in shares)       192,000          
Shares issued upon vesting of equity-based awards, net of tax withholding (1,545)     $ 2   (1,547)      
Equity-based compensation 2,136         2,136      
Currency translation adjustment 0                
Tax expense (benefit) 100                
Change in fair value of interest rate swaps, net of reclassification adjustment and tax expense (340)               (340)
Ending balance (in shares) at Dec. 31, 2025       16,566,000 0        
Ending balance at Dec. 31, 2025 277,493     $ 166 $ 0 241,067 37,243 0 (983)
Beginning balance (in shares) at Sep. 30, 2025   16,373,991 0 16,374,000 0        
Beginning balance at Sep. 30, 2025 284,953     $ 164 $ 0 240,478 44,954 0 (643)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (20,612)                
Ending balance (in shares) at Mar. 31, 2026   16,617,541 0 16,618,000 0        
Ending balance at Mar. 31, 2026 269,417     $ 166 $ 0 244,297 24,342 0 612
Beginning balance (in shares) at Dec. 31, 2025       16,566,000 0        
Beginning balance at Dec. 31, 2025 277,493     $ 166 $ 0 241,067 37,243 0 (983)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (12,901)           (12,901)    
Shares issued as part of employee stock purchase plan (in shares)       48,000          
Shares issued as part of employee stock purchase plan 438         438      
Shares issued upon vesting of equity-based awards, net of tax withholding (in shares)       4,000          
Shares issued upon vesting of equity-based awards, net of tax withholding (13)         (13)      
Equity-based compensation 2,805         2,805      
Currency translation adjustment 17               17
Tax expense (benefit) (500)                
Change in fair value of interest rate swaps, net of reclassification adjustment and tax expense 1,578               1,578
Ending balance (in shares) at Mar. 31, 2026   16,617,541 0 16,618,000 0        
Ending balance at Mar. 31, 2026 $ 269,417     $ 166 $ 0 $ 244,297 $ 24,342 $ 0 $ 612